Sanofi to float drug ingredients manufacturing business on May 6
Sanofi logo at the company’s headquarters during the annual results news conference in Paris, France, February 4, 2022. REUTERS/Benoit Tessier
Register now for FREE unlimited access to Reuters.com
Register
- Sanofi shareholders get 1 EUROAPI share for 23 shares in parent
- Sanofi CFO says France, EU have interest in regional production
- EUROAPI pledges to win over more customers among Sanofi rivals
- EUROAPI seeks growth in drug development services
April 1 (Reuters) – Sanofi (SASY.PA) plans to list its drug ingredients subsidiary EUROAPI on May 6, saying the business is set to grow and improve its profitability as a separate business.
Having received approval from the French markets regulator, the listing on the Euronext Paris exchange is set to take place shortly after a May 3 Sanofi shareholder vote on the listing, the French pharmaceutical giant said on Friday.
Sanofi shareholders will receive one EUROAPI share for 23 shares held in the parent…
